CJC-1295 Ipamorelin 10mg/10mg lyophilized research peptide blend vial
CJC-1295 / Ipamorelin 10mg / 10mg

$135.00

Add to cart

CJC-1295 / Ipamorelin 10mg / 10mg

$135.00

CJC-1295 Ipamorelin is a two-component lyophilized research blend combining a growth-hormone-releasing hormone analog with a selective ghrelin receptor pentapeptide at 10mg each, supplied for receptor-pathway research.

CJC-1295 Ipamorelin 10mg / 10mg Research Peptide Blend

CJC-1295 Ipamorelin combines two synthetic peptides that reach the growth hormone axis through separate receptors, supplied together at 10mg each. CJC-1295 is an analog of growth-hormone-releasing hormone, modified from the native 1-29 fragment to resist enzymatic degradation. Ipamorelin is a selective pentapeptide agonist of the growth hormone secretagogue receptor, the same receptor targeted by the endogenous ligand ghrelin.

Two receptors, one preparation

What makes this pairing a standing subject of laboratory interest is that the two peptides converge on a shared physiological axis from genuinely independent starting points. Research groups examining receptor crosstalk, additive versus independent signaling, or the pharmacological separation of two convergent pathways need both ligands characterized under identical conditions. A matched-strength blend removes one source of variability from that comparison.

Ipamorelin is frequently cited for its selectivity relative to earlier secretagogue compounds, which makes it a useful reference ligand in receptor-binding work. CJC-1295 is of interest for the opposite reason: its modifications to the native sequence make it a case study in how structural changes alter peptide half-life. Investigational contexts include receptor-binding assays, comparative signaling cascade analysis, and peptide stability studies examining how sequence modification affects degradation.

Specifications

  • Components: CJC-1295 and Ipamorelin
  • Label strength: 10mg / 10mg
  • Format: Lyophilized powder, single vial
  • Presentation: Dual-component research blend
  • Intended use: Laboratory research only

Storage and handling

Supplied lyophilized. Hold sealed, cool, dry and away from light until required. As with all peptide preparations, the dry state is markedly more stable than solution, and repeated temperature cycling should be avoided. Retain lot documentation where findings will be compared across separate batches.

This description covers composition and labeled strength for catalog purposes only. No clinical, diagnostic, therapeutic or usage claims are made or implied.

Research Use Only: This product is sold strictly for laboratory research purposes. Not for human or veterinary use. Not for diagnostic, therapeutic, food, cosmetic, or household applications.

FDA Disclaimer: The statements on this website have not been evaluated by the U.S. Food and Drug Administration. The products and information provided by Vepra Peptides are not intended to diagnose, treat, cure, or prevent any disease.

Vepra Peptides is a research chemical supplier. We are not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B.

All products are sold for research, laboratory, or analytical purposes only, and are NOT for human consumption. All sales are final. Customers are responsible for compliance with all applicable laws.